$ACMR

Wang David H sold $540K of ACMR

Wang David H (See Remarks) sold 5,843 shares of ACM Research, Inc. (ACMR) at $92.38 ($0.54M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosure updates the insider activity record but does not introduce new operating or financial information.

02

Market read

Near-term trading relevance is limited; the main value is tracking insider behavior for sentiment/positioning rather than fundamentals.

03

What to watch

Traders may overreact to insider sales; the key missing context is whether other insiders are buying/selling around the same window and whether the plan size is unusual versus prior activity.

Relevance 6/10Novelty 6/10Timing: Filed June 5; sale executed June 3 (post-trade disclosure).

Background

SEC Form 4 discloses insider transactions; this one is an open-market sale by an officer/director/10% owner under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACM Research insider Wang David H sold 5,843 shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Likely minimal immediate price impact; any effect is more sentiment/flow-related than fundamentals.

Evidence & confidence

The filing is an ownership-change disclosure (not earnings/M&A/regulatory action) and explicitly notes a pre-arranged 10b5-1 plan, reducing interpretive weight.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • ACM Research, Inc.

    Subject of the Form 4 insider sale by David H. Wang.

  • David H. Wang

    Officer/Director/10% Owner who sold 5,843 shares on June 3, 2026.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.